Glucose Exposure and Variability with Empagliflozin as Adjunct to Insulin in Patients with Type 1 Diabetes: Continuous Glucose Monitoring Data from a 4-Week, Randomized, Placebo-Controlled Trial (EASE-1)
2017 ◽
Vol 19
(1)
◽
pp. 49-60
◽
2018 ◽
Vol 20
(11)
◽
pp. 758-766
◽
Keyword(s):
Keyword(s):
2017 ◽
Vol 5
(9)
◽
pp. 700-708
◽
Keyword(s):
Keyword(s):
Keyword(s):